• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.

作者信息

Raitanen M P, Tammela T L

机构信息

Division of Urology, Oulu University Central Hospital, Finland.

出版信息

Ann Chir Gynaecol. 1995;84(1):37-41.

PMID:7645909
Abstract

The recurrence rate and the time interval until the first recurrence were analysed in 169 consecutive conservatively treated patients with transitional cell carcinoma of the urinary bladder, in relation to initial tumour grade, number, size and stage, sex and smoking habits, at least five years after the diagnosis of the disease. The recurrence rate was higher among patients with more than three tumours and among patients with an invasive disease, while tumour size, histological grade and sex had no effect on the recurrence rate. The time until the first recurrence was found to be shorter among patients with an invasive disease and those with more than three tumours, and also among females. Smoking did not have any impact on the disease-free interval or on recurrence. We suggest that patients with multiple tumours are at great risk of recurrent disease. If invasion into muscle is found, the risk of recurrences will be high, and transurethral electroresection might not be an adequate form of therapy.

摘要

相似文献

1
Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
Ann Chir Gynaecol. 1995;84(1):37-41.
2
The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.复发性高危浅表性膀胱肿瘤患者根治性膀胱切除术的最佳时机。
BJU Int. 2004 Dec;94(9):1258-62. doi: 10.1111/j.1464-410X.2004.05228.x.
3
Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.T1G2膀胱肿瘤多因素分析中,三个月时的复发及高级别复发作为疾病进展的预后因素。
Urology. 2009 Jun;73(6):1313-7. doi: 10.1016/j.urology.2008.12.047. Epub 2009 Apr 10.
4
Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.pTa/pT1期膀胱癌患者局部复发的危险因素。
Scand J Urol Nephrol. 2008;42(5):417-21. doi: 10.1080/00365590802016302.
5
Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.低剂量卡介苗灌注治疗Ta3期膀胱肿瘤的复发、进展及疗效
J Urol. 2000 Jan;163(1):63-7.
6
Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.台湾患者根治性肾输尿管切除术后原发性上尿路癌预后的显著预测因素。
Eur Urol. 2008 Nov;54(5):1127-34. doi: 10.1016/j.eururo.2008.01.054. Epub 2008 Jan 28.
7
The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.对Ta期和T1期膀胱移行细胞癌患者进行至少20年的随访,观察其多次复发、进展与预后之间的关系。
J Urol. 1995 Jun;153(6):1823-6; discussion 1826-7.
8
Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.根治性膀胱切除术后膀胱癌病理分期中的浅表性(pT2a)和深部(pT2b)肌肉浸润。
J Urol. 2006 Aug;176(2):493-8; discussion 498-9. doi: 10.1016/j.juro.2006.03.065.
9
Surveillance, initial assessment, and subsequent progress of patients with superficial bladder cancer in a prospective longitudinal study. National Bladder Cancer Collaborative Group A (NBCCGA).
Cancer Res. 1977 Aug;37(8 Pt 2):2907-10.
10
The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.膀胱T1期肿瘤患者接受膀胱内丝裂霉素治疗后重复经尿道切除术对复发率和进展率的影响:一项前瞻性随机临床试验。
J Urol. 2006 May;175(5):1641-4. doi: 10.1016/S0022-5347(05)01002-5.

引用本文的文献

1
Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.生活方式与非肌层浸润性膀胱癌的复发、进展及死亡率:现有研究与未来方向
Bladder Cancer. 2020;6(1):9-23. doi: 10.3233/blc-190249. Epub 2020 Mar 28.
2
Epidemiology of urinary bladder cancer: from tumor development to patient's death.膀胱癌流行病学:从肿瘤发生到患者死亡
World J Urol. 2007 Jun;25(3):285-95. doi: 10.1007/s00345-007-0168-5.
3
The health economics of bladder cancer: a comprehensive review of the published literature.
膀胱癌的卫生经济学:已发表文献的综合综述
Pharmacoeconomics. 2003;21(18):1315-30. doi: 10.1007/BF03262330.
4
Prognostic utility of human complement factor H related protein test (the BTA stat Test).人补体因子H相关蛋白检测(BTA stat检测)的预后效用
Br J Cancer. 2001 Aug 17;85(4):552-6. doi: 10.1054/bjoc.2001.1938.